recombinant viral vector vaccine(AlphaVax)

N/A

Report date: 2025/01/26 17:50:42

Base Information

Drug Namerecombinant viral vector vaccine(AlphaVax)
Drug Alias NameMarburg virus vaccine (AlphaVax)filovirus vaccine (AlphaVax)ebola virus vaccine (AlphaVax)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphavax Inc
Inactive CompaniesN/A
Active IndicationsFiloviridae InfectionsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A